🔎 Trials Near Me

Home › Digestive Diseases › Texas › San Antonio

Digestive Diseases clinical trials in San Antonio, TX

5 studies for Digestive Diseases are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 2
  • Gastroenterology Research of San Antonio, San Antonio
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT06598943

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

RecruitingPhase 2
  • Texas Liver Institute, San Antonio
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT07654283

Product Surveillance Registry

RecruitingObservational study
  • San Antonio, San Antonio
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RecruitingPhase 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • and 2 more
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

About Digestive Diseases

Learn about digestive disorders and how your gastrointestinal (GI) system works. Find out what tests you need in case you sense a problem.

More about Digestive Diseases on MedlinePlus

Digestive Diseases trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.